Compare XLO & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XLO | NTWK |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8M | 53.7M |
| IPO Year | 2021 | 1997 |
| Metric | XLO | NTWK |
|---|---|---|
| Price | $8.47 | $4.35 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $28.00 | N/A |
| AVG Volume (30 Days) | ★ 41.7K | 24.3K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 316.67 |
| EPS | N/A | ★ N/A |
| Revenue | $43,766,000.00 | ★ $73,088,687.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $168.77 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 589.88 | 13.40 |
| 52 Week Low | $0.46 | $2.73 |
| 52 Week High | $9.89 | $5.75 |
| Indicator | XLO | NTWK |
|---|---|---|
| Relative Strength Index (RSI) | 43.22 | 46.29 |
| Support Level | $7.47 | $4.20 |
| Resistance Level | $8.80 | $4.47 |
| Average True Range (ATR) | 0.35 | 0.14 |
| MACD | -0.12 | -0.02 |
| Stochastic Oscillator | 15.49 | 27.27 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.